183 related articles for article (PubMed ID: 34496544)
1. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
[No Abstract] [Full Text] [Related]
2. Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus.
Li X; Liu L; Li N; Jia Q; Wang X; Zuo L; Long J; Xue P; Sun Z; Zhao H
J Cancer; 2022; 13(1):76-87. PubMed ID: 34976172
[No Abstract] [Full Text] [Related]
3. [Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia].
Xue JY; Zhu XY; Wei CL; Sun P; Zhang H; Deng J
Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):201-205. PubMed ID: 34109363
[TBL] [Abstract][Full Text] [Related]
4. [Risk prediction of metabolic syndrome and coronary artery disease in overweight and obese populations based on serum metabolomics].
Pei JY; Zhang DD; He H; Zheng LL; Du SZ; Jing ZW
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Dec; 51(12):1247-1255. PubMed ID: 38123207
[No Abstract] [Full Text] [Related]
5. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum/salivary exosomal Alix in patients with oral squamous cell carcinoma.
Nakamichi E; Sakakura H; Mii S; Yamamoto N; Hibi H; Asai M; Takahashi M
Oral Dis; 2021 Apr; 27(3):439-447. PubMed ID: 32688445
[TBL] [Abstract][Full Text] [Related]
7. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
8. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
[TBL] [Abstract][Full Text] [Related]
10. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma.
Tan Y; Yan B; Xue L; Li Y; Luo X; Ji P
Lipids Health Dis; 2017 Apr; 16(1):73. PubMed ID: 28388900
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins.
T A S; Narayan M; Krishnan R; Thayalan D; Gunasekaran N; S P
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4285-4292. PubMed ID: 36580011
[TBL] [Abstract][Full Text] [Related]
12. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
13. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
[TBL] [Abstract][Full Text] [Related]
14. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.
Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T
Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895
[TBL] [Abstract][Full Text] [Related]
15. Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.
Saraswat M; Mäkitie A; Agarwal R; Joenväärä S; Renkonen S
Br J Cancer; 2017 Jul; 117(3):376-384. PubMed ID: 28632724
[TBL] [Abstract][Full Text] [Related]
16. Analysis of metabolomics and transcriptomics data in head and neck squamous cell carcinoma.
Li W; Li Y; Chen Z; Lam AK; Li Z; Liu X; Zhu B; Qiao B
Oral Dis; 2023 May; 29(4):1464-1479. PubMed ID: 34990052
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
18. Blood and Salivary MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Liu D; Xin Z; Guo S; Li S; Cheng J; Jiang H
J Oral Maxillofac Surg; 2021 May; 79(5):1082.e1-1082.e13. PubMed ID: 33516682
[TBL] [Abstract][Full Text] [Related]
19. Corneodesmosin as a potential target of oral squamous cell carcinoma.
Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
